MeSH D001991 - bronchitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Clarithromycin | Biaxin |  | 1991-10-31 |  |  |
| Cefdinir | Omnicef |  | 1997-12-04 |  |  | |
| Able Laboratories | Phenazopyridine, Sulfamethoxazole, Trimethoprim | Sulfamethoxazole Trimethoprim Phenazopyridine |  | 2001-06-26 |  |  |
| Ajanta Pharma | Clarithromycin | Clarithromycin |  | 2019-04-25 |  |  |
| Alembic Pharmaceuticals | Clarithromycin | Clarithromycin |  | 2022-01-31 |  |  |
| Moxifloxacin | Moxifloxacin |  | 2019-02-13 |  |  | |
| Alkem Laboratories | Cefdinir | Cefdinir |  | 2021-02-19 |  |  |
| Allegis Pharmaceuticals | Trimethoprim | Primsol |  | 1995-06-23 |  |  |
| Allergan | Ofloxacin | Ocuflox |  | 1993-07-30 |  |  |
| Trimethoprim, Polymyxin b | Polytrim |  | 1988-10-20 |  |  | |
| Albuterol, Ipratropium | Albuterol Ipratropium |  | 2007-12-31 |  |  | |
| Cefaclor | Cefaclor |  | 1998-02-18 |  |  | |
| Clarithromycin | Clarithromycin |  | 2004-06-24 |  |  | |
| Guaifenesin | Guaifenesin |  | 2015-09-03 |  |  | |
| Dextromethorphan, Guaifenesin | Guaifenesin Dextromethorphan |  | 2015-08-31 |  |  | |
| Pseudoephedrine, Guaifenesin | Guaifenesin Pseudoephedrine |  | 2015-05-27 |  |  | |
| Ipratropium | Ipratropium |  | 1999-04-22 |  |  | |
| Levofloxacin | Levofloxacin |  | 2011-02-10 |  |  | |
| Sulfamethoxazole, Trimethoprim | Sulfamethoxazole Trimethoprim |  | 1984-11-07 |  |  | |
| Trimethoprim | Trimethoprim |  | 1985-06-06 |  |  |
1
2
3
4
5
6
...
17
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
100%2/2
Phase 3
78%32/41
Approved: 27Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
12
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use